AMPH: Amphastar Kompaniya qiymatining sof foydaga nisbati

Amphastar Pharmaceuticals Inc (AMPH) korporativ emblemasi va logotipi

Amphastar Pharmaceuticals (AMPH) uchun tarixiy P/E grafigi foyda qiymatining dinamikasini namoyish etadi, bunda 12.40 ushbu metrika uchun yangi qiymatga aylanadi. Glyukagon savdosi va Baqsimi integratsiyasi bozor kapitalizatsiyasining o'sishini qo'llab-quvvatlaydi. Brend barqarorligi murakkab inyeksiyalar tizimlarining sifatiga asoslangan. Burun orqali yuboriladigan glyukagon va generiklar joriy effektni ta'minlamoqda, shu bilan birga bozor yangi inlyatsiya liniyalarining tasdiqlanishini kutmoqda.

AMPH Amphastar Corp: Narx-foyda koeffitsiyenti 04.07.2022 - 13.11.2026 oraligʻida

Amphastar (AMPH) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi amphastar.com|AMPH - Konsensus maqsadli narx
- bozor kapitallashuvi haqida ma'lumot:
Bozor qiymati Amphastar Pharmaceuticals, Inc.|AMPH - Kompaniyaning to‘liq qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga sof aktivlar qiymati Amphastar Pharmaceuticals|AMPH - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga multiplikatori amphastar.com|AMPH - Kompaniyaning umumiy aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Amphastar Pharmaceuticals|AMPH - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Amphastar Corp|AMPH - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Amphastar Pharmaceuticals, Inc.|AMPH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Amphastar Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi amphastar.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
AMPH - Kompaniyaning sof foydasi|Forvard foyda Amphastar Pharmaceuticals|AMPH - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Amphastar Pharmaceuticals Inc|AMPH - PEG multiplikatori|EV/EBITDA multiplikatori Amphastar Pharmaceuticals, Inc.|AMPH - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Amphastar Pharmaceuticals|AMPH - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati amphastar.com|AMPH - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Amphastar Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
AMPH - Kompaniya daromadi|Kompaniyaning kelajakdagi daromadi amphastar.com|AMPH - Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan forvard narx Amphastar Pharmaceuticals, Inc.
Kompaniyaning har tomonlama tahlili:amphastar.com - AMPH
Amphastar Pharmaceuticals, Inc. yetakchi tovari

Amphastar Pharmaceuticals (AMPH) kompaniyasining flagman dori vositalari savdosi va yuqori marjali generik dori vositalarini bozorga chiqarishi sof foydani bevosita belgilaydi, bu esa aksiyaning bozor qiymatini hisoblashda maxraj vazifasini o'taydi. Emitentning P/E koeffitsiyentini tahlil qilish orqali investor joriy daromadlar prizmasidan investitsiyalarning qoplanish muddatini baholaydi, bunda grafikdagi ekstremal qiymatlar aktivlarning haddan tashqari qimmat baholanganligidan yoki yashirin strukturaviy biznes risklaridan dalolat beradi.

Muhim raqobatchilar

P/E multiplikatori haleon.com|Narx-foyda koeffitsiyenti KVUE (Kenvue)|VRNA (Verona Pharma PLC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Corp MENS|Ligand Corp (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|perrigo.com - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Corp - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos Genomics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati ANI Pharmaceuticals Corp ANIP|Narxning foydaga nisbati MannKind Corporation (MNKD)|PCRX (pacira.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SPRY (ARS Pharmaceuticals, Inc.)|P/E multiplikatori Theravance Biopharma Inc TBPH|AQST - Narxning foydaga nisbati|scPharmaceuticals Inc. (SCPH) - Narx-foyda koeffitsiyenti|tectonictx.com (TECX) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati TNXP (tonixpharma.com)|SXTC (SXT Pharmaceuticals) - P/E multiplikatori|EPRX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BHST|P/E multiplikatori Invizyne (EXOZ)|Narxning foydaga nisbati Oramed Pharmaceuticals Inc. ORMP|Biznesning o‘zini qoplash muddati Entera Bio Ltd (ENTX)|HYFT: Narx-foyda koeffitsiyenti|ABVC BioPharma Inc. - Bozor narxining sof foydaga nisbati|CPIX: P/E multiplikatori|Quantum BioPharma Corp (QNTM) - P/E multiplikatori|Narxning foydaga nisbati FibroGen, Inc.|TELO: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti RANI (Rani Therapeutics)|SNYR (synergychc.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Rallybio RLYB|LEXX (Lexaria Bioscience Corp) - Kapitalizatsiyaning sof foydaga nisbati|Pulmatrix, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati PTHL (Pheton Holdings Ltd)|APM: P/E multiplikatori|Lyra Therapeutics Inc. (LYRA) - P/E multiplikatori|Narxning foydaga nisbati Impact BioMedical|TNFA: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati cbdMD, Inc. (YCBD)|Narx-foyda koeffitsiyenti painreform.com PRFX|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|P/E multiplikatori Lipella Pharmaceuticals Inc LIPO|Optinose - P/E multiplikatori|Pieris Pharma (PIRS) - Narx-foyda koeffitsiyenti|PROC: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati petrospharma.com (PTPI)|Narx-foyda koeffitsiyenti QLI|P/E multiplikatori Acelyrin Inc.|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)